China Finalized the Trade Agreement for Patent Drug with the U.S.
Trade Agreement On January 16, 2020 the U.S. and China finalized the trade agreement that specifies the patent protection rules for drugs. Under the patent protection, biopharmaceutical companies can fill out an application and the term of each new patent is 20 years....
Tracking the Coronavirus With AI: How JHU & BlueDot are Leading Pre-vaccine Outbreak Response
To understand and control the spread of the latest coronavirus (2019-nCOV), a vast array of artificial intelligence and natural language processing tools have been deployed, giving those watching from the Health Sciences field good cause to be optimistic about recent...
The New Science of Arthritis
“Arthritis” does not stand for one single disease, but multiple joint pain or joint diseases. Arthritis is one of the leading diseases that caused physical deformities and disabilities. There are more than 100 different types of arthritis that affect tens of millions of people from…
HEALTHY 2020 We Are One World
CSOFT celebrates the year of the Rat Now that 2019 is behind us, we have an opportunity to reflect on how far we’ve come. As we leave behind a year of drastic change, innately global issues continue to challenge us, for example, the Coronavirus. This virus has caused...
Raising Awareness of Mental Illness
Overview of Mental Health Mental illness is a medical condition that affects changes in emotion, thinking, and behavior. Mental disorders can affect anyone regardless of their age, gender, sexual orientation, and race. Also, it can happen at any age, but the most...
Beigene, the First Pharma Company to Receive FDA’s Approval for Brukinsa
On November 14, 2019, the U.S. Food and Drug Administration gave approval to BeiGene Ltd's lymphoma treatment, Brukinsa. BeiGene is a Chinese biopharmaceutical company that focused on cancer treatments. The treatment "Brukinsa" has been tested on 118 patients with...
China’s National Reimbursement Drug List (NRDL)
What is NRDL? The National Reimbursement Drug List (NRDL) was introduced in 2000 to support medical healthcare and providing patients with basic medical treatments. Between 2000 and 2017, the NRDL has been updated twice, but the reimbursement process is poor. The...
China Introduces Structural Changes to Pharmaceutical Regulations
Beginning of Changes China revised its pharmaceutical regulations by releasing the second draft of the Drug Administration Law of the People's Republic of China (DAL) to the Committee of the National People's Congress of China (NPC) for discussion. The first draft...
FDA Reducing Price of New Drugs Through Drug Competition Action Plan
The Theory At the American Society of Clinical Oncology (ASCO), FDA Commissioner Dr. Scott Gottlieb introduced the Drug Competition Action Plan, which aims to lower new drug pricing by increasing generic (alternative) drug competition in the pharmaceutical market....
China’s New Human Genetic Resources Policy
CHINA’S NEW HUMAN GENETIC RESOURCES POLICY New Regulation Underway On May 28, 2019, the Chinese government published new regulations on the management of Human Genetic Resources (HGRs). The main objective of the government is to observe all HGR- related activities,...
Observing Breast Cancer Awareness Month
Observing Breast Cancer Awareness MonthWhat is Breast Cancer? Breast cancer is a disease where breast cells grow uncontrollably and can spread through the blood and lymph vessels. Cancer develops when the human's genetic growth is messed up. Usually, cell growth...
Reducing the Side Effects of Chemo for Cancer Patients
A new cancer treatment device has been made which reduces the negative effects of chemotherapy on cancer patients.
Life Science Translation in The Digital Age: Fast Changes in a Slow Environment
Life science translation must be done quick and highly accurate to give life science companies the best ROI. Traditionally speaking, however, everything about the life science sector is slow moving. From research and development to regulatory changes and clinical...
DIA Global Conference 2018 – Boston June 24th-28th
It's that time of year again! In just a few short weeks the city of Boston will play host as thousands of people attend the DIA Global Conference. The 2018 annual meeting of the Drug Information Association will be held from June 24th to 28th this year and bring...
CSOFT Health Sciences Provides Live Interpretation Services at the 10th DIA China Conference
From May 23-25, CSOFT’s CSOFT Health Sciences' Life Sciences Unit attended and exhibited at the 10th DIA China Conference held at the Beijing International Convention Center. This year’s event attracted thousands of pharmaceutical R&D professionals from around the...
Life Science Translation and Global Language Trends – Infographic
As with translations for any other industry, life science translation needs are significantly impacted by global linguistic trends. Earlier this week I stumbled upon an interesting article on Visual Capitalist (Visualcapitalist.com) about the world's languages. Did...
How AI is Changing the Face of Translation
As the demand for quality affordable translations is ever increasing, companies are increasingly harnessing artificial intelligence (AI), moving beyond traditional translation memory and terminology management systems. When using artificial intelligence (AI) for...
Big Changes & Growth Coming in 2018 for CSOFT & CSOFT Health Sciences
Last week I had the privilege of traveling to CSOFT offices in San Francisco to meet with colleagues for a variety of meetings, team building exercises, and industry events. It is always an exciting time to meet with colleagues from around the world to celebrate our...
After Brexit – What It Means for Life Sciences
Continuing our conversation on the European Union, this week I'd like to take a look at the UK's withdrawal from the European Union, "Brexit", and the implications for life sciences. Due to the entwined nature of regulatory bodies for the EU, how will governments and...
European Union Translation Requirements
European Union translation requirements can seem overwhelming, as there are currently 24 official languages recognized in the EU. The EU's policy on multilingualism aims to preserve the broad linguistic diversity of Europe as well as foster an environment where...